From the Guidelines
Candidal vulvovaginitis in infants typically presents with symptoms of widespread dermatitis and can be treated with topical antifungal agents.
Symptoms
- Widespread dermatitis due to Candida
Treatment Options
- Topical therapy with antifungal agents, such as clotrimazole or miconazole, is usually effective in treating candidal vulvovaginitis in infants 1
- The treatment regimen for infants may differ from that of adults, as the recommended regimens for vulvovaginal candidiasis in adults include intravaginal agents such as clotrimazole 1% cream (5 g intravaginally daily for 7–14 days) or miconazole 2% cream (5 g intravaginally daily for 7 days), which may not be suitable for infants 1
- In cases of invasive candidiasis, particularly in premature or low-birth-weight neonates, more aggressive treatment may be necessary, but this is not typically the case for candidal vulvovaginitis in otherwise healthy infants 1
- It is essential to note that the diagnosis of candidal vulvovaginitis in infants can be challenging, and a combination of clinical suspicion, microscopy, and culture may be necessary to confirm the diagnosis 1
From the Research
Symptoms of Candidal Vulvovaginitis in Infants
- There are no specific studies provided that directly address the symptoms of Candidal vulvovaginitis in infants.
- However, it can be inferred from the studies on vulvovaginal candidosis in women that the symptoms may include itching, burning, redness, and discharge 2, 3.
Treatment Options for Candidal Vulvovaginitis in Infants
- The provided studies do not specifically address the treatment of Candidal vulvovaginitis in infants.
- However, the studies suggest that local antifungal treatments, such as imidazoles, polyenes, or ciclopirox olamine, may be effective in treating vulvovaginal candidosis in women 2, 3.
- In the case of pregnant women, local treatment is preferred to reduce the risk of vertical transmission, oral thrush, and diaper dermatitis in the newborn 2.
- It is essential to note that the treatment of Candidal vulvovaginitis in infants may require a different approach than in adults, and medical confirmation is necessary before inducing therapy 2.
- There is no information available in the provided studies on the use of new antifungals, such as ibrexafungerp and oteseconazole, in infants 4.